Animal models for perinatal transmission of HIV-1

Pushpa Jayaraman, Nancy Haigwood

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Despite progress in the use of antiretroviral drugs, mother-to-child transmission of HIV still remains a serious medical problem in resource-poor areas. There is a need to find the best method for drug delivery to reduce transmission, while keeping the risk of selection for drug-resistant viral variants low. Even when infection is prevented during pregnancy, the risk of acquiring infection by breast feeding remains significant and in some settings, is unavoidable. The ability of antiretroviral drugs or vaccines to limit transmission by breast milk is unknown. HIV vaccines are still in an early phase of development and have not yet been tested in newborns, in part due to concerns about potential of low immunogenicity due to transplacental transfer of maternal antibodies. Alternative strategies have been proposed to limit transmission using passive prophylaxis by human monoclonal antibody, but to insure product safety, trials have been slowed. Due to such concerns, animal models may provide an alternative for testing efficacy in human newborns. In this review, advances made using such models will be compared for mother-to-child transmission of lenti virus with that of HIV-1. In addition, some perspectives on integrating the data obtained from these models as a groundwork for future clinical work will be presented.

Original languageEnglish (US)
Pages (from-to)2828-2844
Number of pages17
JournalFrontiers in bioscience : a journal and virtual library
Volume11
Issue numberSUPPL. 3
DOIs
StatePublished - 2006
Externally publishedYes

Fingerprint

HIV-1
Animals
Animal Models
Mothers
Pharmaceutical Preparations
Newborn Infant
AIDS Vaccines
Aptitude
Human Milk
Infection
Breast Feeding
Medical problems
Drug delivery
Viruses
Vaccines
Monoclonal Antibodies
HIV
Safety
Pregnancy
Antibodies

Keywords

  • AIDS
  • Animal models
  • Cats
  • Feline
  • FIV
  • HIV-1
  • Mice
  • MIV
  • Mother-to-child transmission
  • Murine
  • Neonates
  • Nonhuman primates
  • Pediatric pathogenesis
  • Review
  • SHIV
  • SIV
  • Therapies
  • Vaccines

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Animal models for perinatal transmission of HIV-1. / Jayaraman, Pushpa; Haigwood, Nancy.

In: Frontiers in bioscience : a journal and virtual library, Vol. 11, No. SUPPL. 3, 2006, p. 2828-2844.

Research output: Contribution to journalArticle

@article{28029d6dc4264098b2e81830671ec4da,
title = "Animal models for perinatal transmission of HIV-1",
abstract = "Despite progress in the use of antiretroviral drugs, mother-to-child transmission of HIV still remains a serious medical problem in resource-poor areas. There is a need to find the best method for drug delivery to reduce transmission, while keeping the risk of selection for drug-resistant viral variants low. Even when infection is prevented during pregnancy, the risk of acquiring infection by breast feeding remains significant and in some settings, is unavoidable. The ability of antiretroviral drugs or vaccines to limit transmission by breast milk is unknown. HIV vaccines are still in an early phase of development and have not yet been tested in newborns, in part due to concerns about potential of low immunogenicity due to transplacental transfer of maternal antibodies. Alternative strategies have been proposed to limit transmission using passive prophylaxis by human monoclonal antibody, but to insure product safety, trials have been slowed. Due to such concerns, animal models may provide an alternative for testing efficacy in human newborns. In this review, advances made using such models will be compared for mother-to-child transmission of lenti virus with that of HIV-1. In addition, some perspectives on integrating the data obtained from these models as a groundwork for future clinical work will be presented.",
keywords = "AIDS, Animal models, Cats, Feline, FIV, HIV-1, Mice, MIV, Mother-to-child transmission, Murine, Neonates, Nonhuman primates, Pediatric pathogenesis, Review, SHIV, SIV, Therapies, Vaccines",
author = "Pushpa Jayaraman and Nancy Haigwood",
year = "2006",
doi = "10.2741/2012",
language = "English (US)",
volume = "11",
pages = "2828--2844",
journal = "Frontiers in Bioscience - Landmark",
issn = "1093-9946",
publisher = "Frontiers in Bioscience",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Animal models for perinatal transmission of HIV-1

AU - Jayaraman, Pushpa

AU - Haigwood, Nancy

PY - 2006

Y1 - 2006

N2 - Despite progress in the use of antiretroviral drugs, mother-to-child transmission of HIV still remains a serious medical problem in resource-poor areas. There is a need to find the best method for drug delivery to reduce transmission, while keeping the risk of selection for drug-resistant viral variants low. Even when infection is prevented during pregnancy, the risk of acquiring infection by breast feeding remains significant and in some settings, is unavoidable. The ability of antiretroviral drugs or vaccines to limit transmission by breast milk is unknown. HIV vaccines are still in an early phase of development and have not yet been tested in newborns, in part due to concerns about potential of low immunogenicity due to transplacental transfer of maternal antibodies. Alternative strategies have been proposed to limit transmission using passive prophylaxis by human monoclonal antibody, but to insure product safety, trials have been slowed. Due to such concerns, animal models may provide an alternative for testing efficacy in human newborns. In this review, advances made using such models will be compared for mother-to-child transmission of lenti virus with that of HIV-1. In addition, some perspectives on integrating the data obtained from these models as a groundwork for future clinical work will be presented.

AB - Despite progress in the use of antiretroviral drugs, mother-to-child transmission of HIV still remains a serious medical problem in resource-poor areas. There is a need to find the best method for drug delivery to reduce transmission, while keeping the risk of selection for drug-resistant viral variants low. Even when infection is prevented during pregnancy, the risk of acquiring infection by breast feeding remains significant and in some settings, is unavoidable. The ability of antiretroviral drugs or vaccines to limit transmission by breast milk is unknown. HIV vaccines are still in an early phase of development and have not yet been tested in newborns, in part due to concerns about potential of low immunogenicity due to transplacental transfer of maternal antibodies. Alternative strategies have been proposed to limit transmission using passive prophylaxis by human monoclonal antibody, but to insure product safety, trials have been slowed. Due to such concerns, animal models may provide an alternative for testing efficacy in human newborns. In this review, advances made using such models will be compared for mother-to-child transmission of lenti virus with that of HIV-1. In addition, some perspectives on integrating the data obtained from these models as a groundwork for future clinical work will be presented.

KW - AIDS

KW - Animal models

KW - Cats

KW - Feline

KW - FIV

KW - HIV-1

KW - Mice

KW - MIV

KW - Mother-to-child transmission

KW - Murine

KW - Neonates

KW - Nonhuman primates

KW - Pediatric pathogenesis

KW - Review

KW - SHIV

KW - SIV

KW - Therapies

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=33744459252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744459252&partnerID=8YFLogxK

U2 - 10.2741/2012

DO - 10.2741/2012

M3 - Article

C2 - 16720355

AN - SCOPUS:33744459252

VL - 11

SP - 2828

EP - 2844

JO - Frontiers in Bioscience - Landmark

JF - Frontiers in Bioscience - Landmark

SN - 1093-9946

IS - SUPPL. 3

ER -